Retrospective Study
Copyright ©The Author(s) 2021.
World J Transplant. Oct 18, 2021; 11(10): 421-431
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.421
Table 1 Comparison of patients over the age of 65 who underwent transplant and died within 90 d from transplant compared to those who survived beyond 90 d
CharacteristicDeath within 90 d, N = 20Survival beyond 90 d, N = 240P value
Age, mean ± SD67.30 ± 1.78 67.81 ± 2.71 0.821
Year of transplant, median (percentiles)2014 (2012-2016)2015 (2013-2018)0.183
Comorbid conditions, n (%)
Obesity6 (30.0)57 (23.8)0.590
CHF6 (30.0)12 (5.0)0.001a
CKD1 (5.0)23 (9.6)0.705
HTN14 (70.0)152 (63.3)0.550
DM9 (45.0)109 (45.4)0.971
CAD8 (40.0)73 (30.4)0.374
PH2 (10.0)9 (3.8)0.203
Arrhythmias3 (15.0)32 (13.3)0.739
Pre-transplant severity of disease
Ascites
None2 (10.0)34 (14.2)0.269
Mild7 (35.0)111 (46.3)
Moderate3 (15.0)45 (18.8)
Severe8 (40.0) 50 (20.8)
Encephalopathy
None3 (15.0)61 (25.4)0.397
Grade 1-217 (85.0)172 (71.7)
Grade 3-40 (0)7 (2.9)
Child-Pugh Score9.8 +/- 1.79.08 +/- 2.00.127
A0 (0)26 (10.5)0.257
B8 (40)116 (48.3)
C12 (60.0)98 (40.8)
Karnofsky performance index53.50 ± 20.155.69 ± 21.60.555
Indication for transplant, n (%)
Cirrhosis16 (80.0)147 (56.5)0.143
NASH6 (30.0)54 (22.5)0.419
Autoimmune2 (10.0)3 (1.3)0.049
Alcohol2 (10.0)32 (13.3)0.999
Hepatitis C2 (10.0)18 (7.5)0.658
Cryptogenic1 (5.0)14 (5.8)0.999
PSC0 (0)11 (4.6)0.999
PBC2 (10.0)11 (4.6)0.263
Hemochromatosis0 (0)4 (1.7)0.999
HCC and cirrhosis4 (20.0)87 (36.3)0.143
Acute liver failure0 (0)6 (2.5)0.999
Primary etiology of liver disease, n (%)
Alcohol related cirrhosis2 (10)46 (19.2)0.55
NASH cirrhosis8 (40)78 (32.5)0.49
Cirrhosis due to viral hepatitis2 (10)48 (20)0.38
Other8 (40)68 (28.3)0.27
Lab values, mean ± SD
Sodium135.70 ± 4.3136.12 ± 4.30.678
INR1.51 ± 0.41.49 ± 0.50.241
Creatinine1.68 ± 1.01.45 ± 1.00.133
Total Bili6.34 ± 6.85.46 ± 7.80.271
MELD-Sodium21.78 ± 8.619.66 ± 9.00.236
Albumin3.16 ± 0.63.18 ± 0.60.889
Table 2 Binary Logistic Regression analysis to calculate adjusted odds ratio for death within 90 d of transplant
Variable
Adjusted OR
Confidence interval
P value
MELD-Na1.020.95-1.090.615
Age at transplant1.090.89-1.320.421
CPS-C vs CPS A and B3.250.86-12.250.081
CHF9.442.89-30.81< 0.0001
Table 3 Outcomes analysis for different age groups
Age category45-54 years55-64 years≥ 65 yearsP value
30-d mortality (n, %)8 (3.0)12 (2.4)10 (3.8)0.55
1-yr mortality (n, %)32 (12.0)75 (15.2)59 (22.7)0.03
ICU LOS
mean ± SD3.80 ± 6.83.99 ± 6.84.17 ± 6.60.320
Median (IQR)2.0 (1.0-3.0)2.0 (1.0-4.0)2.0 (1.0-4.0)
Total hospitalization
mean ± SD13.22 ± 15.414.14 ± 24.016.8 ± 23.90.034
Median (IQR)10.0 (7.0-14.0)10.0 (7.0-15.0)11.0 (8.0-17.0)
Discharge disposition (n = 890) (n, %)
Home182 (76.2)314 (73.4)133 (59.6)0.000
Home or HHC190 (79.5)329 (76.9)142 (63.7)0.000
Any facility other than home [excluding patients who died during hospitalization, n = 854)]42 (18.1)84 (20.3)67 (32.1)0.001
Acute Rehab13 (5.4)7 (4.0)9 (4.0)
LTAC9 (3.8)21 (4.9)13 (5.8)
SNF20 (8.4)45 (10.5)45 (20.2)
Deceased7 (2.9)15 (3.5)14 (6.3)
Hospice01 (0.2)0
Table 4 Cox Regression Survival Analysis for comparison between different age groups for 1-year mortality
FactorHazard ratioP value95%CI
Lower
Upper
MELD-Na1.0110.1740.9951.028
CHF1.4250.2100.8192.480
Obesity0.9070.6180.6171.333
Hypertension0.9670.8390.6971.341
Type 2 diabetes1.2100.2520.8731.678
Coronary artery disease1.0540.7810.7261.532
Age 55-64 vs Age < 551.2520.2930.8241.902
Pulmonary hypertension1.2090.5390.6602.217
Age > 65 vs Age <651.937.0031.2443.017